- Wanhua Chemical reported a preliminary net income of 13.03 billion yuan for the fiscal year.
- The company achieved a preliminary revenue of 182.07 billion yuan.
- The reported preliminary revenue was below the estimated figure of 194.48 billion yuan.
- The financial results are preliminary and not yet final.
- Analyst recommendations include 29 buy ratings, 1 hold rating, and 1 sell rating for Wanhua Chemical.
A look at Wanhua Chemical Group Co A Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 5 | |
| Growth | 3 | |
| Resilience | 2 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Wanhua Chemical Group Co A, a company specializing in pure isocyanate, polymeric isocyanate, polyurethane, and related chemical products, has been assessed using Smartkarma Smart Scores indicating its long-term outlook. The company scored highest in the Dividend category with a top-notch rating, suggesting a strong payout to its shareholders. Despite this, its overall outlook is somewhat tempered by average scores in the Value and Growth factors, reflecting a mixed picture for investors looking for undervalued opportunities and substantial growth potential.
Furthermore, Wanhua Chemical Group Co A scored lower in Resilience and Momentum, hinting at some challenges in terms of stability and market momentum. Investors may want to consider these factors when evaluating the company for long-term investment prospects. Overall, while Wanhua Chemical Group Co A shows strength in dividend payments, its performance in other key areas may require closer scrutiny for those considering investing in the chemical industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
